These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 12607011)

  • 1. [Pharmacotherapy and costs of DRD 88. Chronic obstructive pulmonary disease in hospital].
    Ordóñez Martí-Aguilar MV; Martos Crespo F; Sánchez de la Cuesta y Alarcón F
    Farm Hosp; 2003; 27(1):12-20. PubMed ID: 12607011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thoracic aortic aneurysm repair. Direct hospital cost and Diagnosis Related Group reimbursement.
    Mishra V; Geiran O; Krohg-Sørensen K; Andresen S
    Scand Cardiovasc J; 2008 Feb; 42(1):77-84. PubMed ID: 18273734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
    Rascati KL; Akazawa M; Johnsrud M; Stanford RH; Blanchette CM
    Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic assessment of initial maintenance therapy for chronic obstructive pulmonary disease.
    Akazawa M; Hayflinger DC; Stanford RH; Blanchette CM
    Am J Manag Care; 2008 Jul; 14(7):438-48. PubMed ID: 18611095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan.
    Chiang CH
    Respirology; 2008 Sep; 13(5):689-94. PubMed ID: 18513247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare costs of COPD in Italian referral centres: a prospective study.
    Koleva D; Motterlini N; Banfi P; Garattini L;
    Respir Med; 2007 Nov; 101(11):2312-20. PubMed ID: 17681461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching.
    Akazawa M; Biddle AK; Stearns SC
    Clin Ther; 2008; 30 Spec No():1003-16. PubMed ID: 18640475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
    Jahnz-Rózyk K; Targowski T; From S
    Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of inhaled corticosteroids for chronic obstructive pulmonary disease according to disease severity.
    Sin DD; Golmohammadi K; Jacobs P
    Am J Med; 2004 Mar; 116(5):325-31. PubMed ID: 14984818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and economic analysis of antimicrobial therapy of chronic obstructive pulmonary disease exacerbations.
    Simoens S; Decramer M; De Coster S; Celis G; Laekeman G
    Int J Clin Pract; 2007 Feb; 61(2):200-6. PubMed ID: 17263707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporating tiotropium into a respiratory therapist-directed bronchodilator protocol for managing in-patients with COPD exacerbations decreases bronchodilator costs.
    Drescher GS; Carnathan BJ; Imus S; Colice GL
    Respir Care; 2008 Dec; 53(12):1678-84. PubMed ID: 19025702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study.
    Lu S; Hill J; Fillit H
    Am J Geriatr Pharmacother; 2005 Jun; 3(2):92-102. PubMed ID: 16129386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-utility analysis applied to the treatment of burn patients in a specialized center.
    Sánchez JL; Perepérez SB; Bastida JL; Martínez MM
    Arch Surg; 2007 Jan; 142(1):50-7; discussion 57. PubMed ID: 17224500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the pharmacoeconomic effect of adding tiotropium bromide to the management of chronic obstructive pulmonary disease patients in Singapore.
    Lee KH; Phua J; Lim TK
    Respir Med; 2006 Dec; 100(12):2190-6. PubMed ID: 16635566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
    Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
    Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Coding of diagnoses in chronic obstructive pulmonary disease--economic consequences].
    Stavem K; Bjerke G; Kjelsberg FN; Ruud EA; Saxrud SO
    Tidsskr Nor Laegeforen; 2002 Sep; 122(23):2290-3. PubMed ID: 12448271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population.
    Menzin J; Boulanger L; Marton J; Guadagno L; Dastani H; Dirani R; Phillips A; Shah H
    Respir Med; 2008 Sep; 102(9):1248-56. PubMed ID: 18620852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic burden prior to COPD diagnosis: a matched case-control study in the United States.
    Akazawa M; Halpern R; Riedel AA; Stanford RH; Dalal A; Blanchette CM
    Respir Med; 2008 Dec; 102(12):1744-52. PubMed ID: 18760581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.